Intelligent Bio Shares Slide Amid Sector‑Wide Shifts

Intelligent Bio Solutions Inc. (ticker INBS) reported a decline of 5.64 % during the 24‑hour trading window that closed at 09:18 AM Central European Time on Monday, 26 March 2026. The stock is currently trading at approximately USD 1.59 on major exchanges, with a circulating supply of 3 million shares. At the close, the company’s market capitalization stood at USD 4.8 million, and a total of roughly USD 32.9 k was exchanged in the last 24 hours.

Contextual Performance

  • Recent Trend: Since the close of the previous month, INBS has traded down 7.02 %.
  • Moving Average: The 200‑day simple moving average is at USD 3.53, indicating that the current price is well below its medium‑term average.
  • 52‑Week Range: The highest price in the past year was USD 24.9 on 1 December 2026, while the lowest was USD 1.35 on 14 October 2026. These extremes suggest a significant price swing that recent traders are navigating.

Peer Activity

Within the same 24‑hour period, several peer companies exhibited varied movements:

  • Auddia (AUUD) rose 2.37 % to USD 0.95; market cap USD 5.5 million.
  • Phionx (900100.KS) increased 0.61 % to KRW 1,541; market cap KRW 7.5 billion.
  • Cenntro (CENN) climbed 2.86 % to USD 2.34; market cap USD 5.8 million.
  • Aquabounty (AQB) surged 8.82 % to USD 1.11; market cap USD 5.7 million.
  • Aclarion (ACON) fell marginally 0.26 % to USD 1.93; market cap USD 5.6 million.

The relative stability of many peers contrasts with INBS’s sharper decline, underscoring sector‑specific dynamics at play.

Aclarion’s Product Launch

Adding to the market narrative, Aclarion Inc. (ACON) announced a new product line aimed at adult users. The update highlights:

  • Higher per‑jumper weight capacity and enhanced frame stability.
  • Controlled bounce for heavier landings, supported by a robust enclosure that withstands stronger impacts.
  • A long‑term durability warranty and recognition from several reputable industry bodies for design quality.

This development illustrates a broader industry emphasis on safety, performance, and customer confidence, potentially influencing investor sentiment across related equities.

Company Overview

Intelligent Bio Solutions Inc. is headquartered in New York, United States, and operates within the health‑care sector. The firm focuses on developing non‑invasive, real‑time monitoring and diagnostic tests for patients and primary health practitioners. Its products aim to provide accurate, timely results, thereby transforming patient monitoring and diagnosis. The company serves patients exclusively in the United States and is publicly traded on the Nasdaq stock exchange.

This article presents a snapshot of recent trading activity and contextual market dynamics for Intelligent Bio Solutions Inc. and its peers.